Robert Cyran

Why ‌buy Hugging Face? There’s no obvious return from the open AI platform, but the ​price is only 0.2% of the ​chip maker's $5.5 trln value. There is ⁠merit though in fostering machine learning ​broadly and blocking the emergence of an ​all-dominant closed rival making its own chips.

Tech moguls’ “move fast ‌and break things” ethos is a bad fit for chatbots posing catastrophic risks. As security ​incidents proliferate, regulation becomes inevitable. Pharmaceutical ​trials offer a template for products ⁠promising life-changing benefits, but with heavy uncertainty.

The cost for freight fuel has risen about twice as fast as gasoline used ​by cars. The shock means ​higher shipping prices and inflation. Consumers ⁠have paid $112 bln more at the ​pump since the start of the ​Iran war. With refineries running at 97% capacity, the pain will get worse.

As a regulation debate rages, Nvidia's boss ‌unveiled tools to monitor and shut down rogue agents. They should help rebuild some trust, but an accompanying $150 bln ​stock-buyback hike lays bare the financial incentives. ​A quest for rapid progress means self-policing isn't ⁠enough.

The $2 trln company’s server-rental unit grew 800%, but attractive returns will probably ​fade as chip shortages subside. ​Rockets are boss Elon Musk’s durable ⁠advantage, but mostly as a ​way to support the next big ​thing. AI, wireless networks, chipmaking or even cars beckon.

The ​Facebook founder doesn’t hide his admiration for Roman Emperor ‌Augustus. An agreement allows him to sell new non-voting stock to pay a tax bill. Doing so, gives him a larger ​purse to pursue bigger dreams of conquest while ​retaining absolute control. Caveat emptor applies.

The search giant is part-owner, supplier and rival to Anthropic; the ​Redmond complex allies with OpenAI. ​As partners they reap rich rewards, ⁠growing quarterly sales in their ​server divisions to $64 bln combined. Yet the ​tension between collaboration and competition is growing.

The children’s ​book characters try ​to thwart temptation by hiding ⁠cookies in a ​box. Issue is, they ​can open it. The AI lab’s founders wield power over ​frightening tech but ​impose convoluted structures that add ‌friction. ⁠It can slow unwise acts, but they still get the biggest ​say.

The iPhone maker has largely ​sat out the data-center ​spending spree. Unlike peers, it’s ⁠pumping out more cash, ​sending another $28 bln to shareholders ​last quarter. The boom is nevertheless pushing component prices higher, ​inflicting pain for all ​tech companies in its path.

The ‌health giant spent 20 years buying into new fields like insurance. It now plans to ​spin off its pharmacies. The original ​M&A pitch touted cost cuts and new ⁠sales. A $14 bln market-value plunge shows ​shareholders erasing those synergies and fretting over ​more upheaval.